Estrogen modulates inhibition of return in healthy human females

2012 ◽  
Vol 50 (1) ◽  
pp. 98-103 ◽  
Author(s):  
Lorenza S. Colzato ◽  
Jay Pratt ◽  
Bernhard Hommel
Neuroscience ◽  
2010 ◽  
Vol 167 (3) ◽  
pp. 709-715 ◽  
Author(s):  
L.S. Colzato ◽  
G. Hertsig ◽  
W.P.M. van den Wildenberg ◽  
B. Hommel

1993 ◽  
Vol 27 (2) ◽  
pp. 91-96 ◽  
Author(s):  
Ferran Balada ◽  
Rafael Torrubia ◽  
Maria Arqué

Life Sciences ◽  
1997 ◽  
Vol 60 (12) ◽  
pp. 899-907 ◽  
Author(s):  
Paul D. Kirwin ◽  
George M. Anderson ◽  
Phillip B. Chappell ◽  
Lloyd Saberski ◽  
James F. Leckman ◽  
...  

1992 ◽  
Vol 25 (4) ◽  
pp. 208-213 ◽  
Author(s):  
Ferran Balada ◽  
Rafael Torrubia ◽  
Josep Maria Arqué

2014 ◽  
Vol 222 (3) ◽  
pp. 171-178 ◽  
Author(s):  
Mareile Hofmann ◽  
Nathalie Wrobel ◽  
Simon Kessner ◽  
Ulrike Bingel

According to experimental and clinical evidence, the experiences of previous treatments are carried over to different therapeutic approaches and impair the outcome of subsequent treatments. In this behavioral pilot study we used a change in administration route to investigate whether the effect of prior treatment experience on a subsequent treatment depends on the similarity of both treatments. We experimentally induced positive or negative experiences with a topical analgesic treatment in two groups of healthy human subjects. Subsequently, we compared responses to a second, unrelated and systemic analgesic treatment between both the positive and negative group. We found that there was no difference in the analgesic response to the second treatment between the two groups. Our data indicate that a change in administration route might reduce the influence of treatment history and therefore be a way to reduce negative carry-over effects after treatment failure. Future studies will have to validate these findings in a fully balanced design including larger, clinical samples.


Sign in / Sign up

Export Citation Format

Share Document